Substance use disorders (SUD) and attention deficit disorder with or without hyperactivity (ADHD) are frequently co-morbid, particularly among people under court supervision. The coexistence of these disorders increases the social and legal vulnerability of individuals. Better identification of ADHD in vulnerable people with SUD is essential to improving their care. This project aims to provide appropriate support for this at-risk population.
Adult, under the supervision of the justice system or monitored by a correctional facility
Diagnosis of Substance Use Disorder (SUD)
Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD)
No objection from the patient
Severe or decompensated psychiatric disorders
Severe cognitive impairment
Lack of understanding of the French language
Refusal to participate
Single group
Workshop
Other interventionAssess the 5 workshops, co-constructed by the scientific committee and thanks to feedback from the qualitative study
80% of patients participated in the workshops
The primary outcome measure is the acceptability of the program to participants in the pilot workshops, gathered through: * Semi-structured pre- and post-intervention interviews * A Likert scale * Workshop participation rate (at least 80%)
SF-12 quality of life
The secondary outcome measure will be measured by the SF-12 quality of life, before and after the 5 workshops. The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life.
Click on the lead sponsor to view all of their trials.
